chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Cognitive disorder, Dizziness, Fatigue
Clinical narrative: When I woke up the next morning after the vaccine I had developed a cognitive fog feeling which has been ongoing on since receiving the vaccine.  Feeling as if I had been awake over 36 hr period of time.  I am coherent.  An MRI was performed which was negative but I have cognitive psychotheraphy advisement nearing to see which part of the brain is misfiring.  I have been advised I have an entoxic gate and have failed serial 7s and serial symantics testings.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling abnormal, Full blood count normal, Magnetic resonance imaging normal, Metabolic function test normal, Psychotherapy
Clinical narrative: When I woke up the next morning after the vaccine I had developed a cognitive fog feeling which has been ongoing on since receiving the vaccine.  Feeling as if I had been awake over 36 hr period of time.  I am coherent.  An MRI was performed which was negative but I have cognitive psychotheraphy advisement nearing to see which part of the brain is misfiring.  I have been advised I have an entoxic gate and have failed serial 7s and serial symantics testings.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Mobility decreased, Muscular weakness
Clinical narrative: 3 days after the first injection of the Covid on the left arm the patient developed numbness on the left side of the body.  21 days later, he received a second injection on the right arm and 3 days later developed right-sided body weakness. I saw the patient for the first time on February 17, 2021
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Gait disturbance, Hand deformity, Hypoaesthesia, Myelitis transverse
Clinical narrative: 3 days after the first injection of the Covid on the left arm the patient developed numbness on the left side of the body.  21 days later, he received a second injection on the right arm and 3 days later developed right-sided body weakness. I saw the patient for the first time on February 17, 2021
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hemiparesis, Magnetic resonance imaging spinal abnormal, Magnetic resonance imaging thoracic abnormal, Myelitis transverse
Clinical narrative: 3 days after the first injection of the Covid on the left arm the patient developed numbness on the left side of the body.  21 days later, he received a second injection on the right arm and 3 days later developed right-sided body weakness. I saw the patient for the first time on February 17, 2021
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Death, Hyperhidrosis, Hypotension, Hypoxia
Clinical narrative: Hypotension, hypoxia on 1/19/21. Died on 1/20/21 during hospitalization/ED visit
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Hypotension, Hypoxia
Clinical narrative: Hypotension, hypoxia on 1/19/21. Died on 1/20/21 during hospitalization/ED visit
Age: 75.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Dizziness, Fatigue, Pain in extremity, Palpitations
Clinical narrative: Dizziness; heart palpitations; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th December 2020, the patient received the 1st dose of Shingrix (intramuscular). On 26th December 2020, 1 hr after receiving Shingrix, the patient experienced dizziness and palpitation. On 26th December 2020, the outcome of the dizziness and palpitation were recovered/resolved.   It was unknown if the reporter considered the dizziness and palpitation to be related to Shingrix.  Additional details were provided as follows: The patient received the Shingrix and 1 hour after the vaccination patient experienced dizziness and heart palpitations, which was resolved in 1 & 1/2 to 2 hours. The reporter did not consent to follow up. The reporter does not give permission to contact her health care professional.
Age: 75.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Dizziness, Palpitations
Clinical narrative: Dizziness; heart palpitations; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th December 2020, the patient received the 1st dose of Shingrix (intramuscular). On 26th December 2020, 1 hr after receiving Shingrix, the patient experienced dizziness and palpitation. On 26th December 2020, the outcome of the dizziness and palpitation were recovered/resolved.   It was unknown if the reporter considered the dizziness and palpitation to be related to Shingrix.  Additional details were provided as follows: The patient received the Shingrix and 1 hour after the vaccination patient experienced dizziness and heart palpitations, which was resolved in 1 & 1/2 to 2 hours. The reporter did not consent to follow up. The reporter does not give permission to contact her health care professional.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Lip swelling, Swelling face
Clinical narrative: States 30-40 minutes post injection face and lips began to swell. Took Benadryl x3 and symptoms resolved by next morning
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: States 30-40 minutes post injection face and lips began to swell. Took Benadryl x3 and symptoms resolved by next morning
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cyanosis, Dyspnoea, Feeling abnormal, Pharyngeal paraesthesia, Skin discolouration
Clinical narrative: Approximately 10 mins post vaccination,  I experienced  an ?itching /crawling? feeling in my head.  After another 10-15 mins (total approx 25 mins) I began to feel itching and tightness in my throat.  Within just a couple of minutes, I could no longer speak or breathe.  On site medics administered Epinepherine 0.3 mg x 2, 4 mins apart.  Ems arrived and oxygen was applied and Benadryl 50 mg IV was also administered.  I was transferred by ambulance to Hospital ER for further work up and treatment.  Subsequently after a second, bimodal reaction in ER at almost 2 hrs since vaccine administration., I was admitted to ICU.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Speech disorder
Clinical narrative: Approximately 10 mins post vaccination,  I experienced  an ?itching /crawling? feeling in my head.  After another 10-15 mins (total approx 25 mins) I began to feel itching and tightness in my throat.  Within just a couple of minutes, I could no longer speak or breathe.  On site medics administered Epinepherine 0.3 mg x 2, 4 mins apart.  Ems arrived and oxygen was applied and Benadryl 50 mg IV was also administered.  I was transferred by ambulance to Hospital ER for further work up and treatment.  Subsequently after a second, bimodal reaction in ER at almost 2 hrs since vaccine administration., I was admitted to ICU.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Dyspnoea, Formication, Intensive care, Pruritus
Clinical narrative: Approximately 10 mins post vaccination,  I experienced  an ?itching /crawling? feeling in my head.  After another 10-15 mins (total approx 25 mins) I began to feel itching and tightness in my throat.  Within just a couple of minutes, I could no longer speak or breathe.  On site medics administered Epinepherine 0.3 mg x 2, 4 mins apart.  Ems arrived and oxygen was applied and Benadryl 50 mg IV was also administered.  I was transferred by ambulance to Hospital ER for further work up and treatment.  Subsequently after a second, bimodal reaction in ER at almost 2 hrs since vaccine administration., I was admitted to ICU.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation, Throat tightness
Clinical narrative: Approximately 10 mins post vaccination,  I experienced  an ?itching /crawling? feeling in my head.  After another 10-15 mins (total approx 25 mins) I began to feel itching and tightness in my throat.  Within just a couple of minutes, I could no longer speak or breathe.  On site medics administered Epinepherine 0.3 mg x 2, 4 mins apart.  Ems arrived and oxygen was applied and Benadryl 50 mg IV was also administered.  I was transferred by ambulance to Hospital ER for further work up and treatment.  Subsequently after a second, bimodal reaction in ER at almost 2 hrs since vaccine administration., I was admitted to ICU.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic shock, Electrocardiogram
Clinical narrative: Patient reports she got her COVID vaccine around 5:30 P.M. and approximately 20 minutes later developed airway and tongue swelling. EMS arrived and she was given 0.3 mg IM epinephrine, 125 mg solumedrol, 50 mg benadryl,  2.5 mg versed for anxiety. Patient states she is not much better since receiving it, however per EMS she was doing much better.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Swollen tongue
Clinical narrative: Patient reports she got her COVID vaccine around 5:30 P.M. and approximately 20 minutes later developed airway and tongue swelling. EMS arrived and she was given 0.3 mg IM epinephrine, 125 mg solumedrol, 50 mg benadryl,  2.5 mg versed for anxiety. Patient states she is not much better since receiving it, however per EMS she was doing much better.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardio-respiratory arrest, Respiratory arrest, Resuscitation
Clinical narrative: Pt went to unconscious; reported SOB and then slowly went unresponsive. code blue called immediately, patient still with BP WNL, oxygenating fine, had a pulse. gag reflex+ when oral airway placed. Taken to ED w/ team. Epi IM given, Ativan given, Benadryl given, glucose given. Pt became awake and alert, talking, observed at ED, then discharged to home at 1226
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Loss of consciousness, Unresponsive to stimuli
Clinical narrative: Pt went to unconscious; reported SOB and then slowly went unresponsive. code blue called immediately, patient still with BP WNL, oxygenating fine, had a pulse. gag reflex+ when oral airway placed. Taken to ED w/ team. Epi IM given, Ativan given, Benadryl given, glucose given. Pt became awake and alert, talking, observed at ED, then discharged to home at 1226
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspepsia, Dyspnoea, Flushing, Hypoxia
Clinical narrative: Abdominal pain, pale, hypotensive, tachycardic. Received epi pen and transport to ER
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Tryptase
Clinical narrative: Abdominal pain, pale, hypotensive, tachycardic. Received epi pen and transport to ER
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Hypotension, Pallor, Tachycardia, Tryptase
Clinical narrative: Abdominal pain, pale, hypotensive, tachycardic. Received epi pen and transport to ER
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrioventricular block first degree, Bundle branch block right, C-reactive protein, Chest pain, Dyspnoea
Clinical narrative: The patient is a 34yo female seen about 1 month ago for SOB - it developed 1 week after the COVID vaccine. She was sent to Cardiology and they diagnosed her with pericarditis and she was started on scheduled NSAIDS. - Cardiology recommended ESR, CRP and CBC and they were negative. - CXR was normal - Echocardiogram was suggestive of pericarditis. Cardiology told her to follow up in 1 month is symptoms did not improve and they have not. Also she stated she has developed mild, intermittent peripheral edema that resolves without intervention but this is new.  I am also ordering the cardiac MRI which the cardiologist recommended if symptoms did not improve with NSAIDs.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Fatigue, Full blood count, Lipids, Metabolic function test
Clinical narrative: The patient is a 34yo female seen about 1 month ago for SOB - it developed 1 week after the COVID vaccine. She was sent to Cardiology and they diagnosed her with pericarditis and she was started on scheduled NSAIDS. - Cardiology recommended ESR, CRP and CBC and they were negative. - CXR was normal - Echocardiogram was suggestive of pericarditis. Cardiology told her to follow up in 1 month is symptoms did not improve and they have not. Also she stated she has developed mild, intermittent peripheral edema that resolves without intervention but this is new.  I am also ordering the cardiac MRI which the cardiologist recommended if symptoms did not improve with NSAIDs.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pericarditis, Red blood cell sedimentation rate
Clinical narrative: The patient is a 34yo female seen about 1 month ago for SOB - it developed 1 week after the COVID vaccine. She was sent to Cardiology and they diagnosed her with pericarditis and she was started on scheduled NSAIDS. - Cardiology recommended ESR, CRP and CBC and they were negative. - CXR was normal - Echocardiogram was suggestive of pericarditis. Cardiology told her to follow up in 1 month is symptoms did not improve and they have not. Also she stated she has developed mild, intermittent peripheral edema that resolves without intervention but this is new.  I am also ordering the cardiac MRI which the cardiologist recommended if symptoms did not improve with NSAIDs.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein normal, Chest X-ray normal, Dyspnoea, Echocardiogram abnormal, Full blood count normal
Clinical narrative: The patient is a 34yo female seen about 1 month ago for SOB - it developed 1 week after the COVID vaccine. She was sent to Cardiology and they diagnosed her with pericarditis and she was started on scheduled NSAIDS. - Cardiology recommended ESR, CRP and CBC and they were negative. - CXR was normal - Echocardiogram was suggestive of pericarditis. Cardiology told her to follow up in 1 month is symptoms did not improve and they have not. Also she stated she has developed mild, intermittent peripheral edema that resolves without intervention but this is new.  I am also ordering the cardiac MRI which the cardiologist recommended if symptoms did not improve with NSAIDs.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oedema peripheral, Pericarditis, Red blood cell sedimentation rate normal
Clinical narrative: The patient is a 34yo female seen about 1 month ago for SOB - it developed 1 week after the COVID vaccine. She was sent to Cardiology and they diagnosed her with pericarditis and she was started on scheduled NSAIDS. - Cardiology recommended ESR, CRP and CBC and they were negative. - CXR was normal - Echocardiogram was suggestive of pericarditis. Cardiology told her to follow up in 1 month is symptoms did not improve and they have not. Also she stated she has developed mild, intermittent peripheral edema that resolves without intervention but this is new.  I am also ordering the cardiac MRI which the cardiologist recommended if symptoms did not improve with NSAIDs.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Decreased appetite, Dizziness, Headache, Myalgia
Clinical narrative: severe muscle and joint pain; severe muscle and joint pain; fever 100°F; dizziness; severe headache; no Appetite; This is a spontaneous report from a contactable consumer (patient).  A 71-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EI9262), via an unspecified route of administration on 24Jan2021 at 14:00 on the left arm at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not have COVID prior to vaccination and had no known allergies. The patient previously received the first dose of BNT162B2 (lot number: EH9899) on 03Jan2021 on the left arm for COVID-19 immunization. It was reported that on 25Jan2021, the next day after the vaccination, the patient woke up with severe muscle and joint pain, fever 100°F, dizziness, severe headache and no appetite. The patient took 2 Tylenol and it got better. Six hours later she took another 2 Tylenol because the headache came back; slept a couple of times a day and had a good night's sleep. Next day, she was a little better but still in bed, she fed myself better. The next day she went to the doctor (prior appointment) and was prescribed Meloxicam and Tylenol 6 hours after and was getting better. The outcome of the events was recovered. Post vaccination, the patient has not been tested for COVID.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: severe muscle and joint pain; severe muscle and joint pain; fever 100°F; dizziness; severe headache; no Appetite; This is a spontaneous report from a contactable consumer (patient).  A 71-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EI9262), via an unspecified route of administration on 24Jan2021 at 14:00 on the left arm at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not have COVID prior to vaccination and had no known allergies. The patient previously received the first dose of BNT162B2 (lot number: EH9899) on 03Jan2021 on the left arm for COVID-19 immunization. It was reported that on 25Jan2021, the next day after the vaccination, the patient woke up with severe muscle and joint pain, fever 100°F, dizziness, severe headache and no appetite. The patient took 2 Tylenol and it got better. Six hours later she took another 2 Tylenol because the headache came back; slept a couple of times a day and had a good night's sleep. Next day, she was a little better but still in bed, she fed myself better. The next day she went to the doctor (prior appointment) and was prescribed Meloxicam and Tylenol 6 hours after and was getting better. The outcome of the events was recovered. Post vaccination, the patient has not been tested for COVID.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Erythema, Full blood count, Hypoaesthesia, Pain in extremity
Clinical narrative: HOTNESS, SWELLING OF LEFT ARM, AND PAIN IN NECK.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Peripheral swelling, Skin warm, Urticaria
Clinical narrative: HOTNESS, SWELLING OF LEFT ARM, AND PAIN IN NECK.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Peripheral swelling, Skin warm
Clinical narrative: HOTNESS, SWELLING OF LEFT ARM, AND PAIN IN NECK.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Accidental exposure to product, Contusion, Exposure via skin contact, Pain in extremity, Product administered at inappropriate site
Clinical narrative: Medication leaked out injection site causing suboptimal dose. Dose was repeated later for a total of 3 injections
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skeletal injury, Underdose, Wrong technique in product usage process
Clinical narrative: Medication leaked out injection site causing suboptimal dose. Dose was repeated later for a total of 3 injections
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site extravasation, Product use issue
Clinical narrative: Medication leaked out injection site causing suboptimal dose. Dose was repeated later for a total of 3 injections
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Blood pressure systolic increased, Chest discomfort, Chest pain, Dysphonia
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram T wave inversion, Erythema, Feeling hot, Hypertension
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypopnoea, Injection site pruritus, Injection site rash, Injection site warmth, Oropharyngeal discomfort
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pallor, Pruritus, Rash erythematous, Rash pruritic
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Skin warm, Throat irritation, Troponin normal
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Anaphylactic reaction, Angina pectoris, Arrhythmia, Blood pressure diastolic increased
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure systolic increased, Cardiac telemetry abnormal, Chest crushing, Chest pain
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysphonia, Dyspnoea, Dyspnoea at rest, Echocardiogram, Electrocardiogram T wave inversion
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Extrasystoles, Facial pain, Fatigue, Fibrin D dimer increased
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Heart rate increased, Hyperhidrosis, Hypertension, Hypoaesthesia
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site erythema, Injection site paraesthesia, Injection site pruritus, Injection site urticaria, Limb discomfort
Clinical narrative: she had a reaction to PEG in the lipids of the vaccine; had Anaphylactic shock/anaphylactic reaction; a cardiovascular event /she had ventricular arrhythmias/Premature ventricular contractions; has High blood pressure sustained until today /Blood pressure still elevated to; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse (patient) reported a 55-year-old female received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Feb2021 into right arm at a single dose for covid-19 immunisation. She reported having numerous allergies including fish, seafood, cats, sheep/lanolin, plants, and trees. The patient's concomitant medications were not reported. The patient usually doesn't have high blood pressure, but she had high blood pressure sustained until today, chest pains, hives immediately and itching on right arm where the shot was, felt welted and had different ventricular beats, short of breath. Doctors gave her Solumedrol- was given Morphine for blood pressure. The patient was admitted overnight and Blood pressure still elevated to and PVC (Premature ventricular contractions). The patient wanted to know what she can do to help this. The patient received the first Pfizer Covid vaccine dose on 03Feb2021. Within 1 minute experienced an anaphylactic reaction/shock and a cardiovascular event. She stated she had ventricular arrhythmias and is now on a beta-blocker for treatment. She thought that she had a reaction to PEG in the lipids of the vaccine. She wanted to know where the PEG is derived from.  The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available and temporal relationship, a causal association between BNT162B2 and the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.